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A 59-year-old African-American male with essential hypertension and chronic obstructive 
pulmonary disease presented to the office for routine visit. The oral exam showed severe 
gingival overgrowth (Figure a) that caused his right lower canine to shift downward and 
laterally. No pain, blood, discharge, or halitosis was noticed. However, the patient had moderate 
plaque disease. He was started on nifedipine 14 months prior and had no observed gingival 
overgrowth during a previous routine visit seven months prior. A presumptive diagnosis of 
nifedipine-induced gingival overgrowth was made and nifedipine was stopped. Follow-up six 
months later showed partial resolution (Figure b). 
 
Discussion 
The preferred clinical diagnostic terminology is gingival overgrowth or enlargement. 
Medication-induced gingival hyperplasia refers to a histologic rather than a clinical 
presentation.
1
 Medications associated with gingival overgrowth fall into three categories:  
antiepileptics (primarily phenytoin), immunosuppressants (primarily cyclosporine), and calcium 
channel blockers (primarily nifedipine and verapamil).
2
 The gingiva affected by these 
medications can have hyperplasia and/or hypertrophy. Gingival overgrowth also can occur with 
other anticonvulsants or immunosuppressants, antibiotics, and oral contraceptives.
3
 Causes of 
gingival overgrowth that are non-medication related include acute myelomonocytic leukemia 
(M5, myelomonocytic) and Burkitt’s lymphoma.  
The incidence in the general population is unknown.
4
 The exact mechanism of action is not 
understood. Medications are thought to produce changes in fibroblast function increasing the 
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extracellular matrix of the gingival connective tissue. Dental plaque causes inflammation and 
increases the likelihood of medication-induced gingival overgrowth. This process is not related 
to the systemic dose of the medication, but to its concentration in the saliva and gingival 
connective tissue. Clinically, it can lead to significant disfigurement and difficulty in chewing 
and speech. 
 Treatment for mild or moderate disease includes medication discontinuation or dose 
reduction in addition to plaque control and good oral dental hygiene.5 Scalpel gingivectomy 
remains the treatment of choice in severe cases and necessitates referral to a general dentist or 
periodontist. Metronidazole, azithromycin, and azithromycin toothpaste have shown variable 
degrees of success in treatment.
6
 A recent study found that oral folic acid decreased the incidence 
of phenytoin-induced gingival overgrowth in children.
7
 
    The oral exam is an important part of the general physical exam and commonly overlooked by 
busy physicians. Promoting oral hygiene, early detection of gingival overgrowth and cessation of 
the inciting medication are the cornerstones in management of drug-induced gingival overgrowth 
and preventing its associated morbidity and disfigurement. 
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